Live feed08:30:00·26dPRReleasevia QuantisnowIntelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening MarketByQuantisnow·Wall Street's wire, on your screen.INBS· Intelligent Bio Solutions Inc.Health Care
